Trial Profile
Efficacy and safety of combination of Sofosbuvir and Simeprevir in patients with genotype 1 hepatitis C infection in real world setting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 21 Dec 2015 New trial record